Medical Devices Industry | Healthcare Sector | Dr. Shantanu K. Gaur M.D. CEO | NYSE Exchange | - ISIN |
United States Country | 501 Employees | - Last Dividend | 2 Aug 2023 Last Split | 2 Aug 2023 IPO Date |
Allurion Technologies Inc. is a pioneering medical technology company dedicated to combating obesity, a global epidemic. Situated in Natick, Massachusetts, Allurion Technologies stands at the forefront of innovative weight loss solutions. With a strong focus on both technological advancements and accessibility, the company introduces a groundbreaking approach to weight management that aims to cater to the needs of individuals struggling with being overweight. Through its comprehensive Allurion Program, the company endeavors to deliver a holistic and integrated weight loss journey that is both effective and minimally invasive.
The Allurion Program encapsulates a multi-faceted approach to weight loss, comprising several key components designed to support individuals throughout their weight loss journey: